Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

SubscribeLogin
Published • loading... • Updated

Novo Competitor in Huge Build-Up

Summary by Dagens Industri
Danish pharmaceutical giant Novo Nordisk's obesity tablet Wegovy sells eight times more than competitor Eli Lilly's equivalent in the US market, reports the Wall Street Journal.

2 Articles

BTBT
Lean Right

Novo Competitor in Huge Build-Up

·Borås, Sweden
Read Full Article
Dagens industriDagens industri

Novo Nordisk's Tablets Outclass the Competitor

Danish pharmaceutical giant Novo Nordisk's obesity tablet Wegovy sells eight times more than competitor Eli Lilly's equivalent in the US market, reports the Wall Street Journal.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Dagens industri broke the news on Thursday, July 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Novo Nordisk icon

Novo Nordisk

Eli Lilly icon

Eli Lilly

Wegovy icon

Wegovy

United States icon

United States

Denmark icon

Denmark

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal